| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD-7545 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | BRD1835 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | Sildenafil | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | A-804598 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.013 | 0.6 |
| mRNA | BRD-K85133207 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | ATRA | CTRPv2 | pan-cancer | AAC | 0.016 | 0.6 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |